
Tepapro Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Thiotepa (15mg)
Overview Tepapro Injection
Tepapro Injection treats brain, breast, lung, and ovarian cancers. It's administered alongside other cancer medications during hematopoietic stem cell transplantation (HSCT) and may be used for other conditions as directed by a physician. Administration is typically overseen by a healthcare provider, with dosage and treatment length determined by your condition and specific treatment plan. Benefits may take weeks or months to appear; discontinue only under your doctor's instruction. Common side effects include leukopenia, anemia, thrombocytopenia, elevated liver enzymes, hyperbilirubinemia, mucositis, hemorrhage, diarrhea, hematuria, and rash. Reduced blood cell counts increase infection risk, necessitating regular blood tests to monitor blood cell levels, kidney, liver, and heart function. Prior to treatment, disclose any bleeding disorders, liver or kidney disease, or current infection medications. Interactions with other drugs are possible; inform your doctor of all medications. This injection is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners throughout treatment.
Uses of Tepapro Injection
Malignancies affecting the brain, breast, lungs (non-small cell), and ovaries.
Major Benefits of Tepapro Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Tepapro Injection:
- Decreased white blood cell count (neutrophils)
- Anemia (low number of red blood cells)
- Low blood platelets
- Increased liver enzymes
- Increased bilirubin in the blood
- Mucosal inflammation
- Hemorrhage
- Rash
- Diarrhea
- Blood in urine
How to use Tepapro Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Tepapro Injection works:
Tepapro Injection is an antineoplastic agent that disrupts the genetic structure (DNA and RNA) of cancerous cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Tepapro Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Tepapro Injection during pregnancy is contraindicated due to confirmed risk to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Tepapro Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from the medication.
DrivingUNSAFE
Tepapro Injection may induce adverse reactions impacting driving ability. Dizziness, headache, and blurred vision are potential side effects of Tepapro Injection that could impair driving skills.
KidneySAFE IF PRESCRIBED
Tepapro Injection appears safe for use in individuals with impaired kidney function. Existing evidence indicates dose modification for Tepapro Injection may be unnecessary in this population. Physician consultation is recommended.
LiverCAUTION
Tepapro Injection requires careful administration for individuals with hepatic impairment. Dosage modification of Tepapro Injection might be necessary. Physician consultation is recommended. Routine monitoring of liver function is advisable during treatment.
What if you forget to take Tepapro Injection :
Should you forget a Tepapro Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tepapro Injection
| Label | Value |
|---|---|
| Chemical Type | Thiophosphate Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Alkylating substance |
